LEMAITRE VASCULAR, INC. (LMAT) Gross profit 2016–2025
LEMAITRE VASCULAR, INC. (LMAT) annual gross profit history from SEC filings — each fiscal year as reported.
$178.5MFY2025 · since FY2016: $62.9M → $178.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $178.5M | +18.3% |
| FY2024 | $150.9M | +18.8% |
| FY2023 | $127.0M | +21.1% |
| FY2022 | $104.9M | +3.5% |
| FY2021 | $101.4M | +19.8% |
| FY2020 | $84.6M | +6.0% |
| FY2019 | $79.9M | +8.0% |
| FY2018 | $73.9M | +4.6% |
| FY2017 | $70.7M | +12.3% |
| FY2016 | $62.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More LMAT financial trends
LMAT RevenueLMAT Net incomeLMAT Net marginLMAT Gross marginLMAT Operating incomeLMAT Operating marginLMAT Operating cash flowLMAT Free cash flowLMAT Capital expendituresLMAT Return on equityLMAT Stock buybacksLMAT Dividends paidLMAT Total assetsLMAT Total liabilitiesLMAT Shareholders’ equityLMAT overview →